99 related articles for article (PubMed ID: 20214647)
1. Applying chemometrics approaches to model and predict the binding affinities between the human amphiphysin SH3 domain and its peptide ligands.
Liu L; He D; Yang S; Xu Y
Protein Pept Lett; 2010 Feb; 17(2):246-53. PubMed ID: 20214647
[TBL] [Abstract][Full Text] [Related]
2. Toward quantitative characterization of the binding profile between the human amphiphysin-1 SH3 domain and its peptide ligands.
He P; Wu W; Wang HD; Yang K; Liao KL; Zhang W
Amino Acids; 2010 Apr; 38(4):1209-18. PubMed ID: 19669081
[TBL] [Abstract][Full Text] [Related]
3. Modeling and predicting interactions between the human amphiphysin SH3 domains and their peptide ligands based on amino acid information.
Cai J; Ou R; Xu YS; Yang L; Lin Z; Shu M
J Pept Sci; 2010 Nov; 16(11):627-32. PubMed ID: 20853307
[TBL] [Abstract][Full Text] [Related]
4. Modeling and prediction of binding affinities between the human amphiphysin SH3 domain and its peptide ligands using genetic algorithm-Gaussian processes.
Zhou P; Tian F; Chen X; Shang Z
Biopolymers; 2008; 90(6):792-802. PubMed ID: 18814309
[TBL] [Abstract][Full Text] [Related]
5. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
Hou T; Zhang W; Case DA; Wang W
J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
[TBL] [Abstract][Full Text] [Related]
6. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
Hou T; McLaughlin W; Lu B; Chen K; Wang W
J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
[TBL] [Abstract][Full Text] [Related]
7. Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands.
Liang G; Chen G; Niu W; Li Z
Chem Biol Drug Des; 2008 Apr; 71(4):345-51. PubMed ID: 18318694
[TBL] [Abstract][Full Text] [Related]
8. Structure-based characterization of the binding of peptide to the human endophilin-1 Src homology 3 domain using position-dependent noncovalent potential analysis.
Fu C; Wu G; Lv F; Tian F
J Mol Model; 2012 May; 18(5):2153-61. PubMed ID: 21947444
[TBL] [Abstract][Full Text] [Related]
9. Exploring the activity space of peptides binding to diverse SH3 domains using principal property descriptors derived from amino acid rotamers.
He P; Wu W; Yang K; Jing T; Liao KL; Zhang W; Wang HD; Hua X
Biopolymers; 2011; 96(3):288-301. PubMed ID: 20690173
[TBL] [Abstract][Full Text] [Related]
10. Modeling protein-peptide recognition based on classical quantitative structure-affinity relationship approach: implication for proteome-wide inference of peptide-mediated interactions.
Zhou Y; Ni Z; Chen K; Liu H; Chen L; Lian C; Yan L
Protein J; 2013 Oct; 32(7):568-78. PubMed ID: 24150505
[TBL] [Abstract][Full Text] [Related]
11. Toward prediction of binding affinities between the MHC protein and its peptide ligands using quantitative structure-affinity relationship approach.
Tian F; Lv F; Zhou P; Yang Q; Jalbout AF
Protein Pept Lett; 2008; 15(10):1033-43. PubMed ID: 19075812
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
13. Predicting liquid chromatographic retention times of peptides from the Drosophila melanogaster proteome by machine learning approaches.
Tian F; Yang L; Lv F; Zhou P
Anal Chim Acta; 2009 Jun; 644(1-2):10-6. PubMed ID: 19463555
[TBL] [Abstract][Full Text] [Related]
14. Why ligand cross-reactivity is high within peptide recognition domain families? A case study on human c-Src SH3 domain.
He P; Wu W; Wang HD; Liao KL; Zhang W; Lv FL; Yang K
J Theor Biol; 2014 Jan; 340():30-7. PubMed ID: 24021866
[TBL] [Abstract][Full Text] [Related]
15. QSAR method for prediction of protein-peptide binding affinity: application to MHC class I molecule HLA-A*0201.
Zhao C; Zhang H; Luan F; Zhang R; Liu M; Hu Z; Fan B
J Mol Graph Model; 2007 Jul; 26(1):246-54. PubMed ID: 17275373
[TBL] [Abstract][Full Text] [Related]
16. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
Han S; Liu Q; Wang F; Yuan Z
J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
[TBL] [Abstract][Full Text] [Related]
17. Phage display selection of ligand residues important for Src homology 3 domain binding specificity.
Rickles RJ; Botfield MC; Zhou XM; Henry PA; Brugge JS; Zoller MJ
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10909-13. PubMed ID: 7479908
[TBL] [Abstract][Full Text] [Related]
18. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
Tian F; Yang L; Lv F; Yang Q; Zhou P
Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
[TBL] [Abstract][Full Text] [Related]
19. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
[TBL] [Abstract][Full Text] [Related]
20. Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain.
Hou T; Chen K; McLaughlin WA; Lu B; Wang W
PLoS Comput Biol; 2006 Jan; 2(1):e1. PubMed ID: 16446784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
